Big Movers: ImmunoGen (NASDAQ:IMGN), VirtualScopics Inc. (NASDAQ:VSCP), Alleghany Corporation (NYSE:Y), Sage Therapeutics (NASDAQ:SAGE), Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)


ImmunoGen, Inc. (NASDAQ:IMGN), announced Company management presented at Cowen and Company 35th Annual Health Care Conference in Boston, MA. On Monday shares of ImmunoGen, Inc. (NASDAQ:IMGN) closed at $7.89. Company’s sales growth for last 5 years was 16.40%.

On 26 February, VirtualScopics Inc. (NASDAQ:VSCP) reported a net loss for the fourth quarter of $1.1 million, or 38 cents a share, compared with a net loss of $1 million, or 35 cents a share, in the fourth quarter a year ago. VirtualScopics Inc. (NASDAQ:VSCP) in last trading activity decreased -0.63% to close at $3.16. Company weekly performance is -2.77% while its quarterly performance stands at -19.18%. VirtualScopics Inc. (NASDAQ:VSCP) is -45.98% away from its 52 week high.

On 24 February, Alleghany Corporation (NYSE: Y) reported Q4 EPS of $8.61, $0.25 better than the analyst estimate of $8.36.On last trading day Alleghany Corporation (NYSE:Y) moved up 0.10% to close at $473.02. Its volatility for the week is 1.73% while volatility for the month is 1.67%. Y’s sales growth for past 5 years was 32.40% and its EPS growth for past 5 years was 69.80%. Alleghany Corporation (NYSE:Y) monthly performance is 5.32%.

On 27 February, Sage Therapeutics, Inc. (NASDAQ:SAGE) reported Net loss was $12.4 million for the fourth quarter and $33.8 million for the year ended December 31, 2014, compared to net loss of $5.7 million and $18.3 million for the comparable periods of 2013. Sage Therapeutics, Inc. (NASDAQ:SAGE) has 0.30% insider ownership while its institutional ownership stands at 94.90%. In last trading activity company’s stock closed at $43.89.

On 20 February, ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) confirmed that it has received notice of nomination by Sarissa Capital Management LP of two director candidates for election at the 2015 Annual Meeting. On last trading day Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) fell -1.23% to close at $8.03. Its volatility for the week is 4.79% while volatility for the month is 4.76%. ARIA’s sales growth for past 5 years was 66.20% and its EPS growth for past 5 years was -0.20%. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) monthly performance is 24.69%.


Leave a Reply

Your email address will not be published. Required fields are marked *